Search Results

You are looking at 101 - 110 of 1,605 items for :

  • breast cancer x
  • Refine by access: All content x
Clear All
Britt B M Suelmann Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by Britt B M Suelmann in
Google Scholar
PubMed
Close
,
Carmen van Dooijeweert Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by Carmen van Dooijeweert in
Google Scholar
PubMed
Close
,
Carsten F J Bakhuis Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by Carsten F J Bakhuis in
Google Scholar
PubMed
Close
,
Sabine Linn Department of Medical Oncology, Netherlands Cancer Institute (AVL-NKI), Amsterdam, The Netherlands

Search for other papers by Sabine Linn in
Google Scholar
PubMed
Close
,
Elsken van der Wall Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by Elsken van der Wall in
Google Scholar
PubMed
Close
, and
Paul J van Diest Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by Paul J van Diest in
Google Scholar
PubMed
Close

Introduction Breast cancer is the most common type of invasive cancer among pregnant women ( Smith et al. 2003 ) and has been reported to affect 1 in 3000 to 10,000 pregnancies ( Antonelli et al. 1996 , Loibl et al. 2006 ). The average

Restricted access
Conleth G Murphy Bons Secours Hospital Cork, Medical Oncology, Cork, Ireland
University College Cork, Medicine, Cork, Ireland

Search for other papers by Conleth G Murphy in
Google Scholar
PubMed
Close
and
Maura N Dickler Memorial Sloan-Kettering Cancer Center, Breast Medicine Service, New York, New York, USA
Joan and Sanford I Weill Medical College of Cornell University, Medicine, New York, New York, USA

Search for other papers by Maura N Dickler in
Google Scholar
PubMed
Close

Introduction Approximately 70% of advanced breast cancers are considered ‘hormone responsive’ as defined by expression of the estrogen receptor (ER), progesterone receptor (PR), or both. Various thresholds have been proposed for the level of

Free access
Ton van Agthoven Department of Pathology, Cancer Genomics Center

Search for other papers by Ton van Agthoven in
Google Scholar
PubMed
Close
,
Anieta M Sieuwerts Department of Pathology, Cancer Genomics Center

Search for other papers by Anieta M Sieuwerts in
Google Scholar
PubMed
Close
,
Danielle Meijer Department of Pathology, Cancer Genomics Center

Search for other papers by Danielle Meijer in
Google Scholar
PubMed
Close
,
Marion E Meijer-van Gelder Department of Pathology, Cancer Genomics Center

Search for other papers by Marion E Meijer-van Gelder in
Google Scholar
PubMed
Close
,
Thecla L A van Agthoven Department of Pathology, Cancer Genomics Center

Search for other papers by Thecla L A van Agthoven in
Google Scholar
PubMed
Close
,
Roya Sarwari Department of Pathology, Cancer Genomics Center

Search for other papers by Roya Sarwari in
Google Scholar
PubMed
Close
,
Stefan Sleijfer Department of Pathology, Cancer Genomics Center

Search for other papers by Stefan Sleijfer in
Google Scholar
PubMed
Close
,
John A Foekens Department of Pathology, Cancer Genomics Center
Department of Pathology, Cancer Genomics Center

Search for other papers by John A Foekens in
Google Scholar
PubMed
Close
, and
Lambert C J Dorssers Department of Pathology, Cancer Genomics Center

Search for other papers by Lambert C J Dorssers in
Google Scholar
PubMed
Close

Introduction Estrogens play important roles in the establishment and progression of breast cancer. As a consequence, endocrine treatment modalities have been designed to counter the supportive role of estrogens in breast cancer. In the past

Free access
Shyh-Han Tan Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, 233 South 10th Street, BLSB 309, Philadelphia, Pennsylvania 19107, USA

Search for other papers by Shyh-Han Tan in
Google Scholar
PubMed
Close
and
Marja T Nevalainen Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, 233 South 10th Street, BLSB 309, Philadelphia, Pennsylvania 19107, USA

Search for other papers by Marja T Nevalainen in
Google Scholar
PubMed
Close

, Kindblom et al . 2002 , 2003 ). Autocrine PRL in prostate and breast tissue became important findings, since local production of PRL provided an explanation as to why the results of studies trying to link breast or prostate cancer incidence or progression

Free access
R Kaaks
Search for other papers by R Kaaks in
Google Scholar
PubMed
Close
,
S Rinaldi
Search for other papers by S Rinaldi in
Google Scholar
PubMed
Close
,
T J Key
Search for other papers by T J Key in
Google Scholar
PubMed
Close
,
F Berrino
Search for other papers by F Berrino in
Google Scholar
PubMed
Close
,
P H M Peeters
Search for other papers by P H M Peeters in
Google Scholar
PubMed
Close
,
C Biessy
Search for other papers by C Biessy in
Google Scholar
PubMed
Close
,
L Dossus
Search for other papers by L Dossus in
Google Scholar
PubMed
Close
,
A Lukanova
Search for other papers by A Lukanova in
Google Scholar
PubMed
Close
,
S Bingham
Search for other papers by S Bingham in
Google Scholar
PubMed
Close
,
K-T Khaw
Search for other papers by K-T Khaw in
Google Scholar
PubMed
Close
,
N E Allen
Search for other papers by N E Allen in
Google Scholar
PubMed
Close
,
H B Bueno-de-Mesquita
Search for other papers by H B Bueno-de-Mesquita in
Google Scholar
PubMed
Close
,
C H van Gils
Search for other papers by C H van Gils in
Google Scholar
PubMed
Close
,
D Grobbee
Search for other papers by D Grobbee in
Google Scholar
PubMed
Close
,
H Boeing
Search for other papers by H Boeing in
Google Scholar
PubMed
Close
,
P H Lahmann
Search for other papers by P H Lahmann in
Google Scholar
PubMed
Close
,
G Nagel
Search for other papers by G Nagel in
Google Scholar
PubMed
Close
,
J Chang-Claude
Search for other papers by J Chang-Claude in
Google Scholar
PubMed
Close
,
F Clavel-Chapelon
Search for other papers by F Clavel-Chapelon in
Google Scholar
PubMed
Close
,
A Fournier
Search for other papers by A Fournier in
Google Scholar
PubMed
Close
,
A Thiébaut
Search for other papers by A Thiébaut in
Google Scholar
PubMed
Close
,
C A González
Search for other papers by C A González in
Google Scholar
PubMed
Close
,
J R Quirós
Search for other papers by J R Quirós in
Google Scholar
PubMed
Close
,
M-J Tormo
Search for other papers by M-J Tormo in
Google Scholar
PubMed
Close
,
E Ardanaz
Search for other papers by E Ardanaz in
Google Scholar
PubMed
Close
,
P Amiano
Search for other papers by P Amiano in
Google Scholar
PubMed
Close
,
V Krogh
Search for other papers by V Krogh in
Google Scholar
PubMed
Close
,
D Palli
Search for other papers by D Palli in
Google Scholar
PubMed
Close
,
S Panico
Search for other papers by S Panico in
Google Scholar
PubMed
Close
,
R Tumino
Search for other papers by R Tumino in
Google Scholar
PubMed
Close
,
P Vineis
Search for other papers by P Vineis in
Google Scholar
PubMed
Close
,
A Trichopoulou
Search for other papers by A Trichopoulou in
Google Scholar
PubMed
Close
,
V Kalapothaki
Search for other papers by V Kalapothaki in
Google Scholar
PubMed
Close
,
D Trichopoulos
Search for other papers by D Trichopoulos in
Google Scholar
PubMed
Close
,
P Ferrari
Search for other papers by P Ferrari in
Google Scholar
PubMed
Close
,
T Norat
Search for other papers by T Norat in
Google Scholar
PubMed
Close
,
R Saracci
Search for other papers by R Saracci in
Google Scholar
PubMed
Close
, and
E Riboli
Search for other papers by E Riboli in
Google Scholar
PubMed
Close

Introduction Most of the established epidemiological risk factors for breast cancer are related to alterations in endogenous hormone metabolism ( Pike et al . 1993 , Russo & Russo 1999 , Russo et al . 2000 , Key et al . 2001

Free access
Teeranut Asavasupreechar Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Tōhoku, Japan

Search for other papers by Teeranut Asavasupreechar in
Google Scholar
PubMed
Close
,
Ryoko Saito-Koyama Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Tōhoku, Japan
Department of Pathology, National Hospital Organization, Sendai Medical Center, Sendai, Miyagi, Tōhoku, Japan

Search for other papers by Ryoko Saito-Koyama in
Google Scholar
PubMed
Close
,
Yasuhiro Miki Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Tōhoku, Japan

Search for other papers by Yasuhiro Miki in
Google Scholar
PubMed
Close
,
Keiichi Tamai Division of Cancer Stem Cell, Miyagi Cancer Center Research Institute, Natori, Miyagi, Tōhoku, Japan

Search for other papers by Keiichi Tamai in
Google Scholar
PubMed
Close
,
Jiro Abe Division of Thoracic Surgery, Miyagi Cancer Center, Natori, Miyagi, Tōhoku, Japan

Search for other papers by Jiro Abe in
Google Scholar
PubMed
Close
,
Chihiro Inoue Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Tōhoku, Japan

Search for other papers by Chihiro Inoue in
Google Scholar
PubMed
Close
,
Ikuro Sato Division of Pathology, Miyagi Cancer Center, Natori, Miyagi, Tōhoku, Japan

Search for other papers by Ikuro Sato in
Google Scholar
PubMed
Close
,
Viroj Boonyaratanakornkit Department of Clinical Chemistry and Age-related Inflammation and Degeneration Research Unit, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand

Search for other papers by Viroj Boonyaratanakornkit in
Google Scholar
PubMed
Close
, and
Hironobu Sasano Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Tōhoku, Japan

Search for other papers by Hironobu Sasano in
Google Scholar
PubMed
Close

Introduction Sex steroid hormones and their receptors are well known to play important roles in breast cancer progression. Progesterone receptor (PR) has two main isoforms, PR isoform A (PRA) and PR isoform B (PRB), in human tissues ( Conneely

Restricted access
Yuanzhong Wang Department of Cancer Biology, Beckman Research Institute of the City of Hope, Duarte, California, USA

Search for other papers by Yuanzhong Wang in
Google Scholar
PubMed
Close
,
Yen-Dun Tony Tzeng Department of Cancer Biology, Beckman Research Institute of the City of Hope, Duarte, California, USA
Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Republic of China

Search for other papers by Yen-Dun Tony Tzeng in
Google Scholar
PubMed
Close
,
Gregory Chang Department of Cancer Biology, Beckman Research Institute of the City of Hope, Duarte, California, USA

Search for other papers by Gregory Chang in
Google Scholar
PubMed
Close
,
Xiaoqiang Wang Department of Cancer Biology, Beckman Research Institute of the City of Hope, Duarte, California, USA

Search for other papers by Xiaoqiang Wang in
Google Scholar
PubMed
Close
, and
Shiuan Chen Department of Cancer Biology, Beckman Research Institute of the City of Hope, Duarte, California, USA

Search for other papers by Shiuan Chen in
Google Scholar
PubMed
Close

Introduction Approximately 70% breast cancers are estrogen receptor positive (ER+), and endocrine therapy is the main treatment for ER+ breast cancer patients. Selective ER modulators (e.g. tamoxifen) and aromatase inhibitors (AIs) constitute

Restricted access
S Rinaldi
Search for other papers by S Rinaldi in
Google Scholar
PubMed
Close
,
P H M Peeters
Search for other papers by P H M Peeters in
Google Scholar
PubMed
Close
,
F Berrino
Search for other papers by F Berrino in
Google Scholar
PubMed
Close
,
L Dossus
Search for other papers by L Dossus in
Google Scholar
PubMed
Close
,
C Biessy
Search for other papers by C Biessy in
Google Scholar
PubMed
Close
,
A Olsen
Search for other papers by A Olsen in
Google Scholar
PubMed
Close
,
A Tjonneland
Search for other papers by A Tjonneland in
Google Scholar
PubMed
Close
,
K Overvad
Search for other papers by K Overvad in
Google Scholar
PubMed
Close
,
F Clavel-Chapelon
Search for other papers by F Clavel-Chapelon in
Google Scholar
PubMed
Close
,
M C Boutron-Ruault
Search for other papers by M C Boutron-Ruault in
Google Scholar
PubMed
Close
,
B Téhard
Search for other papers by B Téhard in
Google Scholar
PubMed
Close
,
G Nagel
Search for other papers by G Nagel in
Google Scholar
PubMed
Close
,
J Linseisen
Search for other papers by J Linseisen in
Google Scholar
PubMed
Close
,
H Boeing
Search for other papers by H Boeing in
Google Scholar
PubMed
Close
,
P H Lahmann
Search for other papers by P H Lahmann in
Google Scholar
PubMed
Close
,
A Trichopoulou
Search for other papers by A Trichopoulou in
Google Scholar
PubMed
Close
,
D Trichopoulos
Search for other papers by D Trichopoulos in
Google Scholar
PubMed
Close
,
M Koliva
Search for other papers by M Koliva in
Google Scholar
PubMed
Close
,
D Palli
Search for other papers by D Palli in
Google Scholar
PubMed
Close
,
S Panico
Search for other papers by S Panico in
Google Scholar
PubMed
Close
,
R Tumino
Search for other papers by R Tumino in
Google Scholar
PubMed
Close
,
C Sacerdote
Search for other papers by C Sacerdote in
Google Scholar
PubMed
Close
,
C H van Gils
Search for other papers by C H van Gils in
Google Scholar
PubMed
Close
,
P van Noord
Search for other papers by P van Noord in
Google Scholar
PubMed
Close
,
D E Grobbee
Search for other papers by D E Grobbee in
Google Scholar
PubMed
Close
,
H B Bueno-de-Mesquita
Search for other papers by H B Bueno-de-Mesquita in
Google Scholar
PubMed
Close
,
C A Gonzalez
Search for other papers by C A Gonzalez in
Google Scholar
PubMed
Close
,
A Agudo
Search for other papers by A Agudo in
Google Scholar
PubMed
Close
,
M D Chirlaque
Search for other papers by M D Chirlaque in
Google Scholar
PubMed
Close
,
A Barricarte
Search for other papers by A Barricarte in
Google Scholar
PubMed
Close
,
N Larrañaga
Search for other papers by N Larrañaga in
Google Scholar
PubMed
Close
,
J R Quiros
Search for other papers by J R Quiros in
Google Scholar
PubMed
Close
,
S Bingham
Search for other papers by S Bingham in
Google Scholar
PubMed
Close
,
K T Khaw
Search for other papers by K T Khaw in
Google Scholar
PubMed
Close
,
T Key
Search for other papers by T Key in
Google Scholar
PubMed
Close
,
N E Allen
Search for other papers by N E Allen in
Google Scholar
PubMed
Close
,
A Lukanova
Search for other papers by A Lukanova in
Google Scholar
PubMed
Close
,
N Slimani
Search for other papers by N Slimani in
Google Scholar
PubMed
Close
,
R Saracci
Search for other papers by R Saracci in
Google Scholar
PubMed
Close
,
E Riboli
Search for other papers by E Riboli in
Google Scholar
PubMed
Close
, and
R Kaaks
Search for other papers by R Kaaks in
Google Scholar
PubMed
Close

) have been published on the relationship between total IGF-I and IGFBP-3 concentrations in blood and breast cancer ( Renehan et al . 2004 , Shi et al . 2004 , Sugumar et al . 2004 , Fletcher et al . 2005 ), which indicated an overall increase in

Free access
Marina Brama
Search for other papers by Marina Brama in
Google Scholar
PubMed
Close
,
Sabrina Basciani
Search for other papers by Sabrina Basciani in
Google Scholar
PubMed
Close
,
Sara Cherubini
Search for other papers by Sara Cherubini in
Google Scholar
PubMed
Close
,
Stefania Mariani
Search for other papers by Stefania Mariani in
Google Scholar
PubMed
Close
,
Silvia Migliaccio
Search for other papers by Silvia Migliaccio in
Google Scholar
PubMed
Close
,
Mario Arizzi
Search for other papers by Mario Arizzi in
Google Scholar
PubMed
Close
,
Giuseppe Rosano
Search for other papers by Giuseppe Rosano in
Google Scholar
PubMed
Close
,
Giovanni Spera
Search for other papers by Giovanni Spera in
Google Scholar
PubMed
Close
, and
Lucio Gnessi
Search for other papers by Lucio Gnessi in
Google Scholar
PubMed
Close

KL/c-kit in breast neoplasias. KL and c-kit are high in normal mammary gland, significantly lower in in situ and almost completely undetectable in invasive breast cancer ( Ulivi et al. 2004 , Yared et al. 2004 ). Breast carcinoma is known to

Free access
K S Kimbro Department of Hematology and Oncology, Emory School of Medicine, Winship Cancer Institute, 1365 Clifton Road, NE, Atlanta, Georgia 30322, USA

Search for other papers by K S Kimbro in
Google Scholar
PubMed
Close
and
J W Simons Department of Hematology and Oncology, Emory School of Medicine, Winship Cancer Institute, 1365 Clifton Road, NE, Atlanta, Georgia 30322, USA

Search for other papers by J W Simons in
Google Scholar
PubMed
Close

-inducible factor 1 (HIF-1) complex. HIF-1 is involved in the cancer biology of many endocrine tumors. This review will concentrate on endocrine oncology: HIF-1 in breast cancer and prostate cancer, specifically. New data on HIF-1 signaling and the potential for

Free access